Filing Details

Accession Number:
0001371285-21-000324
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-20 21:38:04
Reporting Period:
2021-12-16
Accepted Time:
2021-12-20 21:38:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1371285 Trupanion Inc. TRUP Hospital & Medical Service Plans (6324) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1673762 Tricia Plouf C/O Trupanion, Inc.
6100 4Th Avenue South, Suite 200
Seattle WA 98108
Co-President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-16 580 $121.69 26,240 No 4 S Direct
Common Stock Disposition 2021-12-16 850 $122.73 25,390 No 4 S Direct
Common Stock Disposition 2021-12-16 1,279 $124.06 24,111 No 4 S Direct
Common Stock Disposition 2021-12-16 641 $124.83 23,470 No 4 S Direct
Common Stock Disposition 2021-12-16 150 $125.50 23,320 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on May 27, 2020 and amended on November 30, 2020, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.22 to $122.12 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.28 to $123.26 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.335 to $124.33 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.375 to $125.26 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.